title: Phace syndrome: is timolol gel a chance for treatment?
authors.affiliation: Pediatric Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Fontana
authors.affiliation: Head of Neuroradiology Unit, Chief of Interventional Neuroradiology - University of Padova, Padova, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Causin
authors.affiliation: U.O.C. Pediatric Surgery, Department of Woman's and Child's Health, University of Padova, Padova, Italy.
authors.forename: F
authors.initials: F
authors.lastname: De Corti
authors.affiliation: Pediatric Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Belloni Fortina
mesh_terms: D000015:Abnormalities, Multiple / Q000188:drug therapy*; D000287:Administration, Topical; D001158:Arteries / Q000002:abnormalities*; D001921:Brain / Q000002:abnormalities*; D003388:Cranial Fossa, Posterior; D005124:Eye Abnormalities / Q000188:drug therapy*; D005782:Gels; D006330:Heart Defects, Congenital / Q000188:drug therapy*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D010641:Phenotype; D012878:Skin Neoplasms / Q000188:drug therapy*; D013577:Syndrome; D013999:Timolol / Q000627:therapeutic use*
chemical_list: D005782:Gels; D013999:Timolol